Clinical Trial: Association Between Fatty Liver and Inflammatory Biomarkers

U.S., June 10 -- ClinicalTrials.gov registry received information related to the study (NCT07636915) titled 'Association Between Fatty Liver and Inflammatory Biomarkers' on June 04.

Brief Summary: The newly adapted definition for MASLD includes evidence for hepatic steatosis by imaging or biopsy with at least one of the five cardiometabolic criteria; BMI >= 25 kg/m2 (>=23 kg/m2 in Asian) or waist circumference >94 cm in men, >80 cm in women, fasting serum glucose >= 126 mg/dL or 2 hour post load glucose level >= 140 mg/dL or HbA1c >= 5.7% or on treatment for type 2 diabetes mellitus ,blood pressure >=130/85 mmHg or antihypertensive treatment, plasma triglycerides >= 150 mg/dL or on lipid lowering drug, and plasma HDL cholesterol < 40 mg/dL...